A detailed history of Pine Bridge Investments, L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 740,827 shares of ABBV stock, worth $123 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
740,827
Previous 730,490 1.42%
Holding current value
$123 Million
Previous $113 Million 19.17%
% of portfolio
1.09%
Previous 1.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1.65 Million - $1.88 Million
10,337 Added 1.42%
740,827 $135 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $53.1 Million - $59.8 Million
385,609 Added 111.81%
730,490 $113 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $8.6 Million - $9.95 Million
64,354 Added 22.94%
344,881 $51.4 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $544,483 - $677,574
-4,109 Reduced 1.44%
280,527 $37.8 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $1.4 Million - $1.61 Million
-9,691 Reduced 3.29%
284,636 $45.4 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $614,234 - $736,628
-4,441 Reduced 1.49%
294,327 $47.6 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $5.81 Million - $6.67 Million
-43,302 Reduced 12.66%
298,768 $40.1 Million
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $3.02 Million - $3.84 Million
21,936 Added 6.85%
342,070 $52.4 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $5.95 Million - $7.38 Million
45,058 Added 16.38%
320,134 $51.9 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $3.37 Million - $4.26 Million
31,366 Added 12.87%
275,076 $37.2 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $8.25 Million - $9.37 Million
77,546 Added 46.67%
243,710 $26.3 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $2.2 Million - $2.45 Million
-20,882 Reduced 11.16%
166,164 $18.7 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $6.31 Million - $6.95 Million
61,668 Added 49.19%
187,046 $20.2 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $10 Million - $13.5 Million
-124,262 Reduced 49.78%
125,378 $13.4 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $5.62 Million - $6.6 Million
-65,448 Reduced 20.77%
249,640 $21.9 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $13.4 Million - $18 Million
182,895 Added 138.35%
315,088 $30.9 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $14,706 - $22,296
228 Added 0.17%
132,193 $10.1 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $19.9 Million - $24.9 Million
-276,163 Reduced 67.67%
131,965 $11.7 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $186,168 - $223,828
-2,956 Reduced 0.72%
408,128 $30.9 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $4.95 Million - $6.33 Million
75,401 Added 22.46%
411,084 $29.9 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $1.96 Million - $2.3 Million
-25,348 Reduced 7.02%
335,683 $27.1 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $2.26 Million - $2.78 Million
29,002 Added 8.73%
361,031 $33.3 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $9.4 Million - $10.5 Million
105,738 Added 46.73%
332,029 $31.4 Million
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $288,373 - $341,210
-3,212 Reduced 1.4%
226,291 $21 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $12.5 Million - $16.8 Million
136,362 Added 146.4%
229,503 $21.7 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $4.73 Million - $5.19 Million
52,862 Added 131.24%
93,141 $9.01 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $961,345 - $1.23 Million
13,763 Added 51.9%
40,279 $3.58 Million
Q2 2017

Aug 11, 2017

BUY
N/A
26,516
26,516 $1.92 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.